Trials / Completed
CompletedNCT00210067
A Study in Subjects With Retinal Detachment
A Double-Masked, Randomized, Dose-Ranging Study of a Single Intravitreal (IVT) Injection of INS37217 Intravitreal Injection in Subjects With Retinal Detachment
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- —
- Age
- —
- Healthy volunteers
- —
Summary
The purpose of this trial is to access the tolerability of INS37217 Intravitreal Injection when administered intravitreally in subjects with macula-on or macula-off rhegmatogenous retinal detachment (RRD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | denufosol tetrasodium (INS37217) Intravitreal Injection |
Timeline
- Start date
- 2001-05-01
- Primary completion
- 2002-06-01
- Completion
- 2002-06-01
- First posted
- 2005-09-21
- Last updated
- 2015-10-09
Source: ClinicalTrials.gov record NCT00210067. Inclusion in this directory is not an endorsement.